Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial

Published:2007 Issue:5 Volume:56 Page:1424-1432
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

van Dongen Henrike,van Aken Jill,Lard Leroy R.,Visser Karen,Ronday H. Karel,Hulsmans Harry M. J.,Speyer Irene,Westedt Marie-Louise,Peeters André J.,Allaart Cornelia F.,Toes René E. M.,Breedveld Ferdinand C.,Huizinga Tom W. J.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference24 articles.

1. Can we accurately predict the development of rheumatoid arthritis in the preclinical phase?

2. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors

3. Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study

4. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study

Cited by 333 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of Rheumatoid Arthritis in At-Risk Individuals: Current Status and Future Prospects;Drugs;2024-07-02

2. Therapeutic strategies in preclinical stages of rheumatoid arthritis;Polish Archives of Internal Medicine;2024-05-29

3. May Traditional Chinese Medicine Reduce the Risk of Developing Rheumatoid Arthritis? An One-armed Prospective Study;Clinical Complementary Medicine and Pharmacology;2024-03

4. Autoantibody-negative rheumatoid arthritis: still a challenge for the rheumatologist;The Lancet Rheumatology;2023-12

5. Clinical significance of anti-cyclic citrullinated peptide (anti-CCP) antibodies in rheumatoid arthritis: Literature review;SN Comprehensive Clinical Medicine;2023-11-17